City
Epaper

Leading India biopharma standardizes on Veeva Vault PromoMats to speed scientific content distribution

By ANI | Updated: March 25, 2022 18:20 IST

Veeva Systems (NYSE: VEEV) today announced one of India's fastest-growing biopharma companies, Bharat Serums and Vaccines Limited (BSV), is standardizing on Veeva Vault PromoMats to accelerate its end-to-end content lifecycle for scientific and promotional materials. BSV is adopting a scalable digital content platform for streamlined approvals and better content reuse to future-proof its operations in preparation for expansion into global markets.

Open in App

(NYSE: VEEV) today announced one of India's fastest-growing biopharma companies, Bharat Serums and Vaccines Limited (BSV), is standardizing on to accelerate its end-to-end content lifecycle for scientific and promotional materials. BSV is adopting a scalable digital content platform for streamlined approvals and better content reuse to future-proof its operations in preparation for expansion into global markets.

For over five decades, BSV has developed a range of biological, biotech, and pharmaceutical products for women's health, infertility (IUI/IVF), and critical, and emergency care.

"At BSV, we remain committed to innovation and research to deliver treatments and cures that serve our patients better," said Dr Swashraya Shah, Chief Medical Officer at BSV. "With Vault PromoMats, organizations now have the ability to prioritize and share scientific digital content with physicians in real-time, while ensuring compliance and effective data asset management. Vault PromoMats also assists in content analytics to increase effectiveness."

"We are excited that BSV has standardized on Vault PromoMats to easily publish approved assets to digital channels and to accelerate its time to market through content reuse," said Anantha Nema, India country manager, Veeva Systems. "With a digital content platform, biopharmas in India can optimize their promotional material review cycles to keep up with the increased demand for timely information."

helps life sciences companies speed the creation, review, and distribution of compliant content. Built-in digital asset management enables content reuse and reduces spend on promotional materials. Marketing teams can easily publish and withdraw content from digital channels as needed to ensure only approved assets are in use. Vault PromoMats also supports accelerated content approval and time to market through streamlined medical, legal, and regulatory reviews, and offers visibility into industry benchmarks and activities across assets to drive content strategy.

Additional InformationFor more on Veeva Vault PromoMats, visit: Connect with Veeva on LinkedIn: Follow @veevasystems on Twitter:

This story is provided by BusinessWire India.will not be responsible in any way for the content of this article. (ANI/BusinessWire India)

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Bharat serums and vaccines limitedAnantha nemaNyse
Open in App

Related Stories

BusinessVTEX Partners with Retail Insights to Strengthen Its Capabilities in India

BusinessIntroducing BEAUTY&YOU 2023: Supporting the next generation of Indian beauty entrepreneurs and creators

BusinessThe 4th PropertyGuru Asia Property Awards (India) will Help Promote the Country's Finest Real Estate on an International Stage

BusinessPhilips unveils India's first Air Styler for Men: BHA301/10 for salon-like hairstyling at home

BusinessLaunched today: Infosys Topaz - An AI-first offering to accelerate business value for global enterprises using generative AI

Business Realted Stories

BusinessIndia's direct tax collections surge 15.6% to Rs 27 lakh crore in 2024-25

BusinessCentre tells states to onboard eMaap portal to help consumers

BusinessMinister urges young IRS officers to strive for Viksit Bharat goal

BusinessMotilal Oswal reports Rs 63.2 crore loss in Q4, first in 5 years

BusinessPoonawalla Fincorp Q4 net profit plunges 81 pc to Rs 62 crore